Results 21 to 30 of about 400,631 (298)

Pharmacokinetics and population pharmacokinetics in pediatric oncology [PDF]

open access: yesPediatric Blood & Cancer, 2019
AbstractPharmacokinetic research has become increasingly important in pediatric oncology as it can have direct clinical implications and is a crucial component in individualized medicine. Population pharmacokinetics has become a popular method especially in children, due to the potential for sparse sampling, flexible sampling times, computing of ...
Sebastiaan D.T. Sassen   +3 more
openaire   +3 more sources

Robust physiologically based pharmacokinetic model of rifampicin for predicting drug–drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2022
P‐glycoprotein (P‐gp) is an efflux transporter that plays an important role in the pharmacokinetics of its substrate, and P‐gp activities can be altered by induction and inhibition effects of rifampicin.
Ryuta Asaumi   +4 more
doaj   +1 more source

Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology [PDF]

open access: yes, 2014
Pharmacokinetic/pharmacodynamic (PKPD) modelling is used to describe and quantify dose-concentration-effect relationships. Within paediatric studies in infectious diseases and immunology these methods are often applied to developing guidance on ...
Hoare, RL   +5 more
core   +1 more source

BDNF-loaded PDADMAC-heparin multilayers: a novel approach for neuroblastoma cell study

open access: yesScientific Reports, 2023
Biomaterial science has contributed tremendously to developing nanoscale materials for delivering biologically active compounds, enhancing protein stability, and enabling its therapeutic use.
Maria Dąbkowska   +7 more
doaj   +1 more source

Pharmacokinetic research in children: an analysis of registered records of clinical trials. [PDF]

open access: yes, 2011
BACKGROUND: Reported off-label/unlicensed prescribing rates in children range from 11% to 80%. Research into pharmacokinetic profiles of children's medicines is essential in the creation of more knowledge on the safety and efficacy of medicines in ...
Rademaker, Carin MA   +5 more
core   +1 more source

Open questions on bioequivalence: the case of cholecalciferol

open access: yesItalian Journal of Medicine, 2013
Cholecalciferol or vitamin D3 is an endogenous substance with the typical problems of bioavailability/bioequivalence of this class of substances. A previous trial has shown that, if administered orally at a dose of 800-10,000 IU and bioassayed as its 25 ...
Antonio Marzo   +2 more
doaj   +1 more source

A “middle‐out approach” for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2023
Simplified physiologically based pharmacokinetic (PBPK) models using estimated tissue‐to‐unbound plasma partition coefficients (Kpus) were previously investigated by fitting them to in vivo pharmacokinetic (PK) data.
Estelle Yau   +4 more
doaj   +1 more source

Simultaneous Quantification of 3′- and 6′-Sialyllactose in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study

open access: yesMolecules, 2021
Sialyllactose (SL), an acidic oligosaccharide, has immune-protective effects against pathogens and helps with the development of the immune system and intestinal microorganisms.
Seok-In Jang   +4 more
doaj   +1 more source

Partial Validation of Ultra Performance Liquid Chromatography Method for Quantification of Isoniazid-Pyrazinamide in Human Samples [PDF]

open access: yesJournal of Pure and Applied Chemistry Research, 2021
Isoniazid (INH) and pyrazinamide (PZA) are first-line drugs in the treatment of meningitis of tuberculosis, in addition to rifampicin. The use of these drugs will determine the success of therapy to kill Mycobacterium tuberculosis in brain tissue that is
Vycke Yunivita   +4 more
doaj  

The Impact of Serum Protein Adsorption on PEGylated NT3–BDNF Nanoparticles—Distribution, Protein Release, and Cytotoxicity in a Human Retinal Pigmented Epithelial Cell Model

open access: yesPharmaceutics, 2023
The adsorption of biomolecules on nanoparticles’ surface ultimately depends on the intermolecular forces, which dictate the mutual interaction transforming their physical, chemical, and biological characteristics. Therefore, a better understanding of the
Maria Dąbkowska   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy